Company / Return on Assets (ROA)
Silo Pharma, Inc. Return on Assets (ROA) History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Assets (ROA)
-59.3%
FY2025
5-year range
-205.2% / -49.9%
FY2021-FY2025
Trend
-18.7%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from -50.5% to -59.3% over the past 2 years.
Based on SEC 10-K filings.
-59.3% in FY2025 with a 5-year CAGR of +145.9%.
Declined from -50.5% to -59.3% over the past 2 years.
Return on Assets (ROA) over time
Growth rates
- 3-Year Change
- -
- 5-Year Change
- +145.9pp
- 10-Year Change
- -
Key checks
Key Insights
- In FY2025, return on assets (roa) decreased 18.7% year-over-year.
- Peak return on assets (roa) was recorded in FY2024.
- Lowest return on assets (roa) in the period was in FY2020.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 0.67 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Assets (ROA)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -59.3% | -18.7% |
| FY2024 | -49.9% | +1.1% |
| FY2023 | -50.5% | +75.4% |
| FY2020 | -205.2% | -4.5% |
| FY2019 | -196.3% | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026